NexGel, Inc. (NXGL)
0.2991
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 11:40
NexGel Enterprise Value : 9.153M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 9.153M |
| September 04, 2026 | 9.339M |
| September 03, 2026 | 9.561M |
| September 02, 2026 | 9.639M |
| September 01, 2026 | 9.742M |
| August 31, 2026 | 9.749M |
| August 28, 2026 | 9.683M |
| August 27, 2026 | 9.663M |
| August 26, 2026 | 9.722M |
| August 25, 2026 | 9.722M |
| August 24, 2026 | 9.955M |
| August 21, 2026 | 9.47M |
| August 20, 2026 | 10.03M |
| August 19, 2026 | 10.19M |
| August 18, 2026 | 9.999M |
| August 17, 2026 | 9.911M |
| August 14, 2026 | 11.75M |
| August 13, 2026 | 11.01M |
| August 12, 2026 | 10.25M |
| August 11, 2026 | 10.40M |
| August 10, 2026 | 9.784M |
| August 07, 2026 | 9.955M |
| August 06, 2026 | 9.557M |
| August 05, 2026 | 10.26M |
| August 04, 2026 | 10.35M |
| Date | Value |
|---|---|
| August 03, 2026 | 10.37M |
| July 31, 2026 | 10.30M |
| July 30, 2026 | 10.57M |
| July 29, 2026 | 10.60M |
| July 28, 2026 | 10.54M |
| July 27, 2026 | 10.50M |
| July 24, 2026 | 10.53M |
| July 23, 2026 | 10.44M |
| July 22, 2026 | 10.26M |
| July 21, 2026 | 10.49M |
| July 20, 2026 | 10.59M |
| July 17, 2026 | 10.84M |
| July 16, 2026 | 10.47M |
| July 15, 2026 | 10.73M |
| July 14, 2026 | 10.82M |
| July 13, 2026 | 10.84M |
| July 10, 2026 | 11.29M |
| July 09, 2026 | 11.26M |
| July 08, 2026 | 11.22M |
| July 07, 2026 | 11.60M |
| July 06, 2026 | 11.51M |
| July 02, 2026 | 11.75M |
| July 01, 2026 | 11.76M |
| June 30, 2026 | 11.13M |
| June 29, 2026 | 7.078M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 210.25B |
| Align Technology, Inc. | 9.954B |
| AngioDynamics, Inc. | 591.77M |
| Accuray, Inc. | 177.77M |
| Alphatec Holdings, Inc. | 1.912B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.606M |
| Revenue (Quarterly) | 3.686M |
| Total Expenses (Quarterly) | 7.321M |
| EPS Diluted (Quarterly) | -0.4033 |
| Gross Profit Margin (Quarterly) | 30.09% |
| Profit Margin (Quarterly) | -97.83% |
| Earnings Yield | -239.8% |
| Normalized Earnings Yield | -266.57 |